Clinical Trial Update: Novel Adjuvants for Peptide-Based Melanoma Vaccines [Phase 1]

View source ↗

Summary

This update notes that a Phase 1 trial evaluating novel adjuvants for peptide-based melanoma vaccines has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Snippet

Sponsor: University of Southern California | Conditions: Melanoma | Phase 1 | Status: COMPLETED